Patent · US Active

Compounds for activating TGF-β signaling

US8097645B2 · kind B2 · utility

1Cited by
0References
13Claims
0Family size

Assignees

Inventors

Key dates

Filing dateOct 10, 2008
Grant dateJan 17, 2012
Priority date—
Expiry dateSep 5, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D409/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods for treatment and prevention of disorders and conditions characterized by reduced TGF-β signaling are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.